Morphologic changes in hepatocyte nuclei of streptozotocin (SZ)-induced diabetic mice

Experimental and Toxicologic Pathology

Volumn 49, Issue 3-4, 1997, Pages 295-299

  Doi, Kukio ^a   Yamanouchi, Jun ^a   Kume, Eisuke ^b   Yasoshima, Akira ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Diabetes; Hepatocyte; Nucleus; Streptozotocin

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; LIVER CELL; LIVER CELL NUCLEUS; MALE; MORPHOLOGY; NONHUMAN; STREPTOZOCIN DIABETES;

ANIMALIA;

EID: 0030768276     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0940-2993(97)80041-3     Document Type: Article

References (19)

1. ANDREW W, BROWN HM, JOHNSON JB: Senile changes in the liver of mouse and man, with special reference to the similarity of the nuclear alterations. Am J Anat 1943; 72: 199-221.
2. ARMOCIDA AD, ITAGAKI S, KUME E, et al.: Hepatic lesion in streptozotocin (SZ)-induced diabetic mice. J Toxicol Pathol 1994; 7: 87-90.
3. BERMAN LD, HAYES JA, SIBAY TM: Effect of streptozotocin in the Chinese hamster (Cricetulus griserus). J Natl Cancer Inst 1973; 51: 1287-1294.
4. GAHAN PB, MIDDLETON J: Hepatocyte euploidization is a typical mammalian physiological speczialization. Comp Biochem Physiol 1982; 71A: 345-348.
5. GELLATLY JBM: The natural history of hepatic parenchymal nodule formation in colony of C57BL mice with reference to the effect of diet. In: BUTLER WH, NEWBERNE PM (eds.): Mouse hepatic neoplasia. Elsevier Amsterdam 1975.
6. HERBST M: Glycogenous hepatonuclear inclusions in the aged mouse - an electron microscopic study of the histogenesis of nuclear inclusions. Pathol Europ 1976; 11: 69-79.
7. JAMES J, TAS J, BOSCH KS, DE MEERE AJP, et al.: Growth pattern of rat hepatocytes during postnatal development. Eur J Cell Biol 1979; 19: 222-226.
8. KUME K, ITAGAKI S, DOI K: Cytomegalic hepatocytes and bile duct hyperplasia in streptozotocin-induced diabetic mice. J Toxicol Pathol 1994a; 7: 261-265.
9. KUME E, ITAGAKI S, NAGASHIMA Y, et al.: Glomerular lesions in unilaterally nephrectomized and diabetic (UN-D) mice. J Vet Med Sci 1992; 54: 1085-1090.
10. KUME E, OHMACHI Y, ITAGAKI S, et al.: Hepatic changes of mice in the subacute phase of streptozotocin (SZ)-induced diabetes. Exp Toxicol Pathol 1994b; 46: 368-374.
11. LEDUC EH, WILSON JW: An electron microscope study of intranuclear inclusions in mouse liver and hepatoma. J Biophys Biochem Cytol 1959; 6: 427-430.
12. LEVINE BS, HENRY MC, PORT CD, et al.: Toxicologic evaluation of streptozotocin in mice, dogs and monkeys. Drug Chem Toxicol 1980; 3: 201-212.
13. NADAL C, ZAJDELA F: Poliploidie somatique dans le foie de rat. I. Le role des cellules binuclees dans la genes des cellules poliploidies. Exp Cell Res 1966; 42: 99-116.
14. OKAWA H, DOI K: Neoplastic lesions in streptozotocin-treated rats. Exp Anim 1983; 32: 77-84.
15. RAKIETEN N, RAKIETEN ML, NADKARNI MV: Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother Rep 1963; 29: 91-98.
16. SCHEIN PS, O'CONNELL MJ, BLOM J, et al.: Clinical antitumor actitivity and toxicity of streptozotocin (NSC-85998). Cancer 1974; 34: 993-1000.
17. SIBAI TM, HAUSLER HR, HAYES JA: The study and effect of streptozotocin (NSC-37917) rendered diabetic Chinese hamsters. Ann Opthalmol 1971; 3: 596-601.
18. STEFFES MW, MAUER SM: Diabetic glomerulopathy in man and experimental animal models. Int Rev Exp Pathol 1984; 26: 147-175.
19. WEISS RB: A review of its pharmacology, efficacy, and toxicity. Cancer Treatment Rept 1982; 66: 427-438.